The Globe and Mail reports in its Friday, March 7, edition that TD Cowen analyst Brian Morrison continues to rate Martinrea International "buy." The Globe's David Leeder writes in the Eye On Equities column that Mr. Morrison lowered his share target to $12 from $13. Analysts on average target the shares at $14.42. Mr. Morrison says in a note: "The Q4/24 results missed consensus, while 2025 guidance forecast an improving financial outlook with the midpoint for implied EBITDA in line with consensus. Despite a challenging year, Martinrea is maintaining its commitment of generating attractive annual FCF. While tariffs remain a cautionary headwind, we believe they will prove temporary and may lead to attractive returns in H2/25." The Globe reported on Nov. 14 that Mr. Morrison had reaffirmed his "buy" recommendation for Martinrea International. The shares could then be had for $9.65. The Globe reported on Nov. 15 that BMO Capital Markets analyst Tamy Chen continued to rate Martinrea International "outperform." It was then worth $9.68. The Globe reported on March 6 that CIBC World Markets analyst Krista Friesen downgraded Martinrea to "neutral" from "outperformer." The shares could then be had for $7.95.